Larimar Therapeutics (LRMR) Surges On FDA Breakthrough Therapy Designation

The designation covers adults and children with the rare disease and was based on data from an ongoing open-label study. Here’s what investors need to know.Larimar Therapeutics shares are climbing with conviction. What’s driving LRMR stock higher?FDA Grants Breakthrough Therapy StatusBreakthrough Therapy status is designed to speed development of drugs that may improve outcomes over current therapies for serious conditions. Larimar reported that FDA communications following a recent START program meeting su ...